{
  "id": "7da0bbaf6824ab96",
  "title": "Tonix Pharmaceuticals Announces Licensing TNX - 4900 , a Selective Sigma - 1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University",
  "description": "20251216T191500Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/16/1411301/tonix-pharmaceuticals-announces-licensing-tnx-4900-a-selective-sigma-1-receptor-antagonist-for-chronic-neuropathic-pain-from-rutgers-university/",
  "published_at": "20251216T191500Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/16/1411301/tonix-pharmaceuticals-announces-licensing-tnx-4900-a-selective-sigma-1-receptor-antagonist-for-chronic-neuropathic-pain-from-rutgers-university/",
    "url_mobile": "",
    "title": "Tonix Pharmaceuticals Announces Licensing TNX - 4900 , a Selective Sigma - 1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University",
    "seendate": "20251216T191500Z",
    "socialimage": "https://ml.globenewswire.com/media/YTMyMGQxOTQtNzQ2ZC00MjVjLWE5ZWQtZmY4MzA0YmQ2YjJkLTEwMjI2ODUtMjAyNS0xMi0xNi1lbg==/tiny/Tonix-Pharmaceuticals-Holding-.png",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}